EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, MTVA: Metavia Inc

07 Nov 25 15:59
LAST:

0.9098

CHANGE:
 0.06		OPEN:
0.8445		HIGH:
1.2000		ASK:
0.0000		VOLUME:
41.26M
CHG(%):
6.85		PREV:
0.8500		LOW:
0.7595		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.02001.06000.82000.908243.48M
06 Nov 250.86050.89820.75300.8500726.4K
05 Nov 251.19001.35000.81001.000020.14M
04 Nov 250.98001.18000.98001.0800317.8K
03 Nov 250.99001.00980.97901.000051.7K
31 Oct 251.00001.01000.97020.992536.1K
30 Oct 250.98000.98000.95100.974881.7K
29 Oct 250.98000.99200.97000.98929.7K
28 Oct 251.01001.01000.96170.975131.5K
27 Oct 250.97990.98000.95000.966822.2K

COMPANY PROFILE

Name:Metavia Inc
About:MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.
Sector:Healthcare
Industry:Biotechnology
Address:545 Concord Avenue, Cambridge, MA, United States, 02138
Website:https://www.metaviatx.com
CIK:0001638287
FIGI:BBG009YPPXR8

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:0.976.4%
MA10:0.977.0%
MA20:0.998.7%
MA50:0.954.6%
MA100:0.8013.2%
MA200:1.0010.1%
STO9:11.64 
STO14:11.64 
RSI14:39.32 
WPR14:-74.70
MTM14:-0.09
ROC14:-0.09 
ATR:0.11 
Week High:1.3548.4%
Week Low:0.7520.8%
Month High:1.3548.4%
Month Low:0.7510.1%
Volatility:42.68 

RECENT SPLITS

Date Ratio
21 Dec 20231-8
13 Sep 20221-30
31 Dec 20191-25